TBX1 and spindle cell hemangioma: Furthermore, qRT-PCR analyses indicated that when added in stage 2 (Additional file 1: Figure S2A-F), SCH, but not Losma, reduced Brachyury mRNA levels, as well as the expression of the hematopoietic stem cell marker CD34.